Cyclopharm Ltd has released a press release.
Cyclopharm USFDA Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Cyclopharm
- Half Year 2021 Financial Results
- CYC First Half Trading Update
- Managing Directors Address to Shareholders
- CYC 2021 AGM Presentation
- Chairmans Address to Shareholders
Later from Cyclopharm
- S&P DJI Announces March 2022 Quarterly Rebalance
- 1H 2022 Business Update - Record Revenues
- Technegas Used In Multicenter COVID Study
- Half Year 2022 Results
- Cyclopharm Receives $1.64m R&D Refund
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm